The iconic rise of Viagra has long been a example of pharmaceutical success, yet its position within the broader sector now raises questions about future returns . Generic versions are undercutting exclusivity , leading to concerns that investing in companies closely tied to Viagra's former position could be a speculative strategy, especially given